Zidovudine (ZDV) has antibacterial activity against many members of the family Enterobacteriaceae, including ,ug/ml) and ddl (MIC50, 8 ,ug/ml; MIC range, 2 to 125 jg/ml) had concentration-dependent activity. Anti-SabnoneUla activity was not observed for ddC or ACV. Nine Escherichia coli blood isolates were inhibited by ZDV (MIC50, 0.125 ,ug/ml; MIC range, 0.031 to 1 ,ug/ml) to a greater degree than they were by ddl (MIC50, 62.5 ,ug/ml; MIC range, 31 to >62.5 ,ug/ml). Inoculum size affected susceptibility to ZDV and ddI for Salmonela and E. coli isolates. Resistance to ZDV or to ddl could be induced in vitro in SalmoneUa isolates, but cross-resistance was not observed. These results indicate that at concentrations achieved during the treatment of HIV infection, ZDV has activity against nontyphoidal salmonellae, although resistance can develop. ddI, ddC, and ACV at currently used dosages would not be expected to be effective in the prevention or treatment of Salmonella infections.